Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Early Complete Portrait And Letter

Research Leaders

5 sponsors active, led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Early Complete Portrait And Letter1
  • Delayed Plain Portrait And Letter1
  • Early Plain Portrait And Letter1
  • No Intervention1
  • Delayed Complete Portrait1

Active Sponsors

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
  • British Columbia College of Oral Health Professionals1
  • Ministry of Health, British Columbia1
  • British Columbia Centre for Disease Control1
  • University of British Columbia1

Top Investigators

Related Conditions

  • Oral Infection1
  • Solid Tumors1
  • Antibiotics1
  • Clindamycin1
  • Febrile Neutropenia1

Activity Timeline